Lilly To HRSA: Co-Pay Coupons Better For Patients Than 340B

By Michelle M. Stein / November 10, 2020 at 3:34 PM
Eli Lilly indicated in a letter to the Health Resources and Services Administration that its co-pay coupons are more helpful for patients than the 340B program, shortly after CMS finalized a proposal to let Obamacare plans exclude brand drug makers’ coupons from out-of-pocket calculations even when there are no generics available. HRSA in June warned Lilly that its policy to severely limit 340B discounts via contract pharmacies for Cialis -- a policy the drug maker subsequently implemented in July and...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.